CompletedNCT01016873
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
PHASE2 · 230 planned enrolment
- Countries listed
- 5
- Registry update
- December 5, 2014
Registry Intervention View
Iray
Trial registrations containing the exact intervention label Iray.
Exact registry label · Not reported
5 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
1 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
UnknownNCT01521065
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
PHASE2 · 500 planned enrolment
- Countries listed
- 1
- Registry update
- April 26, 2013
UnknownNCT01516294
IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD
Phase not reported · 12 planned enrolment
- Countries listed
- 1
- Registry update
- November 1, 2012
UnknownNCT01217762
Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
PHASE1 · 62 planned enrolment
- Countries listed
- 1
- Registry update
- January 19, 2012
WithdrawnNCT01339949
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
Phase not reported · 0 planned enrolment
- Countries listed
- 2
- Registry update
- December 30, 2011